CARISMA Therapeutics Inc (CARM)
0.98
-0.01
(-0.88%)
USD |
NASDAQ |
Sep 20, 16:00
0.99
+0.01
(+1.02%)
After-Hours: 18:51
CARISMA Therapeutics Profit Margin (Quarterly): -121.4% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -121.4% |
| March 31, 2024 | -558.7% |
| December 31, 2023 | -488.6% |
| September 30, 2023 | -559.3% |
| June 30, 2023 | -558.3% |
| Date | Value |
|---|---|
| March 31, 2023 | -759.9% |
| December 31, 2022 | -448.6% |
| September 30, 2022 | -710.9% |
| June 30, 2022 | -549.3% |
| March 31, 2022 | -1.38K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.38K%
Minimum
Mar 2022
-121.4%
Maximum
Jun 2024
-613.1%
Average
-558.5%
Median
Profit Margin (Quarterly) Benchmarks
| Moderna Inc | -578.7% |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -240.4% |
| Return on Assets | -78.38% |
| Return on Invested Capital | -240.4% |
| Operating Margin (Quarterly) | -126.9% |
| Return on Net Operating Assets | -706.1% |